Lung Health

From surgeons to students, Team Rush runners are taking on the Chicago Marathon to raise funds for the programs and patients closest to their hearts

Rush research helps people live longer, better lives after a lung cancer diagnosis

By the time lung cancer signs and symptoms develop, it’s harder to treat, so screening and prevention are crucial

In this episode of Rounding at Rush, thoracic surgeon Nicole Geissen, DO, medical oncologist Koosha Paydary, MD, and radiation oncologist Gaurav Marwaha, MD, discuss their and other RUSH MD Anderson clinicians’ efforts diagnosing and treating non-small cell lung cancer.

Helen Ross, MD, is a thoracic medical oncologist and an expert in the care of patients with cancers of the chest, including lung cancers, mesothelioma and thymic cancers. She is director of research and clinical trials at RUSH MD Anderson. She is also a professor in the Department of Internal Medicine and serves as interim chief of the Division of Hematology, Oncology and Cellular Therapy.

Beatrice Karnoscak survived both breast and lung cancer. Early screening saved her life each time.

Diagnosed with lung cancer at age 28, Aurora Lucas now advocates for others with the disease

Mary Jo Fidler, MD, is a thoracic oncologist and professor of Internal Medicine at RUSH University Medical Center. She is the Medical Oncology Section Chief in the RUSH Cancer Center and is the national principal investigator for the ADAURA trial, which is studying the effects of postoperative Osimertinib in resected EGFR+ lung cancer patients.

Chicago magazine list includes pulmonology, allergy and immunology specialists

"It's the only way we have to catch lung cancer early"